We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-9.65%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.77B
AUM Growth
-$912M
Cap. Flow
-$611M
Cap. Flow %
-34.49%
Top 10 Hldgs %
80.33%
Holding
75
New
9
Increased
8
Reduced
26
Closed
14

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$24.8M
2
NAT icon
Nordic American Tanker
NAT
+$14.3M
3
QRVO icon
Qorvo
QRVO
+$7.65M
4
TWX
Time Warner Inc
TWX
+$7.36M
5
TCOM icon
Trip.com Group
TCOM
+$5.42M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$41.5M
2
AGN.PRA
Allergan plc
AGN.PRA
+$21.4M
3
MMYT icon
MakeMyTrip
MMYT
+$18M
4
RICE
Rice Energy Inc.
RICE
+$13.9M
5
CMBT
CMB.TECH NV
CMBT
+$10.7M

Sector Composition

Rank Sector Weight
1 Healthcare 57.85%
2 Consumer Discretionary 4.04%
3 Communication Services 3.86%
4 Financials 2.91%
5 Energy 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QRVO icon
26
Qorvo
QRVO
$7.63B
$6.99M 0.39%
+105,000
New +$7.65M
PTEN icon
27
Patterson-UTI
PTEN
$3.87B
$6.7M 0.38%
291,100
+129,400
+80% +$2.68M
NEX
28
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$6.46M 0.36%
339,922
+151,100
+80% +$2.37M
WFC icon
29
Wells Fargo
WFC
$261B
$5.96M 0.34%
98,300
-11,410
-10% -$644K
NXST icon
30
Nexstar Media Group
NXST
$5.6B
$5.71M 0.32%
73,023
-8,232
-10% -$553K
AVXS
31
DELISTED
AveXis, Inc. Common Stock
AVXS
$5.51M 0.31%
49,823
– –
ADAP
32
DELISTED
Adaptimmune Therapeutics
ADAP
$5.48M 0.31%
853,885
-5,507
-0.6% -$42.5K
BABA icon
33
Alibaba
BABA
$269B
$5.09M 0.29%
+29,500
New +$5.29M
HIMX
34
Himax Technologies
HIMX
$2.2B
$5.04M 0.28%
+483,500
New +$5.25M
TCOM icon
35
Trip.com Group
TCOM
$27.5B
$5M 0.28%
+113,300
New +$5.42M
CALM icon
36
Cal-Maine
CALM
$4.28B
$4.57M 0.26%
102,896
-20,500
-17% -$914K
GNRT
37
DELISTED
Gener8 Maritime, Inc.
GNRT
$4.38M 0.25%
+660,940
New +$3.16M
COHR icon
38
Coherent
COHR
$55.2B
$3.97M 0.22%
84,509
-51,084
-38% -$2.29M
EQT icon
39
EQT Corp
EQT
$33.2B
$3.89M 0.22%
+125,509
New +$4.11M
TRCO
40
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$3.21M 0.18%
+75,544
New +$3.11M
NAT icon
41
PUT
Nordic American Tanker
NAT
$1.37B
$2.51M 0.14%
1,086,200
-553,900
-34% -$2.29M
BMRN icon
42
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.42M 0.08%
15,923
+32
+0.2% +$2.78K
BLUE
43
DELISTED
bluebird bio
BLUE
$1.24M 0.07%
536
-838
-61% -$1.7M
TSRO
44
DELISTED
TESARO, Inc.
TSRO
$962K 0.05%
11,605
-6,302
-35% -$618K
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.66B
$959K 0.05%
17,231
-39,718
-70% -$2.1M
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$4.25B
$935K 0.05%
31,046
-29,486
-49% -$943K
ICPT
47
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$809K 0.05%
13,854
-7,000
-34% -$441K
GLF
48
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$615K 0.03%
+26,980
New +$757K
HYG icon
49
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$599K 0.03%
6,870
– –
TCON
50
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$397K 0.02%
625
-916
-59% -$553K
1
2
3

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q4 2017 Portfolio in Review

As of Q4 2017, QVT Financial held 75 positions worth $1.77B, down 34% from $2.68B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

QVT Financial withdrew a net $611M in Q4 2017, closing 14 positions and reducing 26 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 48% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in Qorvo worth $6.99M.

  • QVT Financial's largest Q4 2017 buy was Qorvo: 105,000 shares worth $6.99M.
  • QVT Financial added most to State Street SPDR S&P Biotech ETF in Q4 2017, an estimated $24.8M increase.
  • QVT Financial's biggest Q4 2017 reduction was MakeMyTrip, cutting an estimated $18M.
  • QVT Financial fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $41.5M.
  • QVT Financial's ten largest holdings make up 80% of its $1.77B portfolio in Q4 2017.
  • QVT Financial opened 9 new positions and closed 14 in Q4 2017.
  • QVT Financial's portfolio value fell 34% quarter-over-quarter to $1.77B.

Based on QVT Financial's 13F filing for Q4 2017, filed 14 Feb 2018.